Searched for
WOCKHARDT FDA APPROVAL
Delhi HC allows Intas to sell cancer drug Bevatas, sets aside order favouring Sun PharmaThe Delhi High Court division bench has ruled in favor of Intas Pharmaceuticals, allowing the company to introduce its anti-cancer medicati...02 Jun, 2026, 12.05 AM IST- Aegis Logistics shares rally 4% as Q4 profit rises 45% YoY; Board recommends dividendAegis Logistics shares rose sharply after the company reported a 45% year-on-year rise in Q4 FY26 consolidated net profit to Rs 413 crore, ...01 Jun, 2026, 12.09 PM IST
- Infosys, Tech Mahindra, TCS and other IT stocks jump up to 5%. What’s driving the rally?Indian IT stocks rose sharply on Monday, lifting the Nifty IT index nearly 3%, as investors reassessed AI-related fears, attracted by attra...01 Jun, 2026, 11.51 AM IST
- Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....01 Jun, 2026, 10.11 AM IST
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...01 Jun, 2026, 07.44 AM IST
- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...31 May, 2026, 05.00 PM IST
- Wockhardt secures US FDA approval for antibiotic ZaynichWockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...30 May, 2026, 11.17 PM IST
- Zydus Therapeutics' saroglitazar drug granted priority review by US FDAZydus Therapeutics' drug saroglitazar has received priority review from the US FDA. This drug treats primary biliary cholangitis, a liver d...28 May, 2026, 09.51 PM IST
- US FDA review boosts odds for Wockhardt’s NCE success story: Vishal ManchandaWockhardt’s breakthrough respiratory drug Zaynich moves a step closer to market as the US FDA accepts it for review, boosting approval odds...02 Dec, 2025, 09.11 AM IST
- Don’t see any fundamental movement in Ranbaxy, Wockhardt: Praful Bohra, Nirmal BangYou take Wockhardt, Ranbaxy, Strides Arcolab, all these companies, all these names have sort of a problem with the FDA.03 Apr, 2014, 03.43 PM IST
- Expect Wockhardt to cross around Rs 1,200 in next 2-3 years: G Chokkalingam"Wockhardt's management will work hard and they will try to get back the status in two to three years," Chokkalingam said.17 Dec, 2013, 05.13 PM IST
- Wockhardt in trouble after USFDA issues warning letter, missive accuses co of obstructing inspectionDrug regulator has issued a warning letter to pharma co accusing it of obstructing its team from inspecting.26 Jul, 2013, 05.15 AM IST
- Wockhardt gets USFDA tentative nod for generic rhinitis drugPharmaceutical and biotechnology firm Wockhardt today said it has received tentative approval from USFDA to sell generic version of Sanofi ...20 Oct, 2010, 02.19 PM IST
- Wockhardt gets USFDA approval for Ceftazidime injectionCeftazidime is the generic name for the brand Fortaz, sold in the US by Glaxo Smithkline.16 Oct, 2008, 06.19 PM IST
- Wockhardt gets US nod for Cefprozil tabsPharma company Wockhardt Ltd on Wednesday said it has received US Food and Drug Administration (USFDA) approval for Cefprozil tablets, an a...20 Jun, 2007, 12.30 PM IST
- Wockhardt gets US FDA nod to mkt painkillers in USWockhardt Ltd today said it has got US FDA approval to market painkiller tablets containing a combination of Dextropropoxyphene napsylate a...20 Mar, 2007, 12.00 PM IST
- Wockhardt plans to restart production of human insulinWockhardt is planning to restart production of human recombinant insulin Wosulin (50:50), for which the State Food and Drug Administration ...24 Feb, 2007, 04.26 AM IST
Load More
